ASX Share rice
Tue 18 May 2021 - 11:10:am (Sydney)

EOF Share Price

ECOFIBRE LIMITEDEOFPharmaceuticals, Biotechnology & Life Sciences

EOF Company Information


Ecofibre Limited




Drug Manufacturers-Specialty & Generic


680 George Street Sydney NSW Australia 2000


61 7 3265 7630

CEO, MD & Director:

Mr. Eric Wang

CFO & Joint Company Sec.:

Mr. Jonathan Brown

VP of Global Operations:

Mr. Adam Cantwell

Chief Technology Officer:

Mr. Alastair Bor

Chief Science Officer:

Dr. Alex Capano

Gen. Counsel & Joint Company Sec.:

Ms. Robin Sheldon

Chief Operating Officer of Ananda Health:

Mr. Jerry Newton

Chief Strategy Officer:

Mr. John Ryan

Chief Revenue Officer:

Mr. Chuck Schneider

Chief Innovation Officer & Chief Sustainability Officer:

Mr. Mark Sunderland

Company Overview:

Ecofibre Limited, together with its subsidiaries, engages in breeding, growing, processing, and distributing hemp products in the United States and Australia. It offers protein powders, dehulled hemp seeds, and hemp seed oil products. The company also produces hemp nutraceutical products for human and pet consumption, as well as topical creams and salves; and develops hemp related fiber products. It sells its products through wholesalers and distributors, as well as pharmacy stores under the Ananda Food and Woolworths Macro brand names. The company was founded in 2009 and is based in Sydney, Australia.

EOF Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Profit Margin:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


QuarterlyEarnings Growth(YOY):


EOF CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Borrowings:


Net Income:


Total Cash From Operating Activities:




Other Cashflow From Investing Activities:


Change To Inventory:


Change To Account Receivables:


Capital Expenditures:


EOF Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Other Operating Expenses:


Interest Expense:


Income Tax Expense:


Total Revenue:


Cost Of Revenue:


EOF Balance Sheet

Balance Sheet Date:


Intangible Assets:


Total Liabilities:


Total Stockholder Equity:


Other Current Liabilities:


Total Assets:


Common Stock:


Other Current Assets:


Retained Earnings:


Other Assets:




Total Current Liabilities:


Property - Plant & Equipment:


Net Tangible Assets:


Total Current Assets:


Long-Term Debt:


Net Receivables:


Short-Term Investments:




Accounts Payable:


Short-Term Investments:


Non Current Liabilities Total:


EOF Share Price History

EOF News

17 May, 2021
Deutsche Bank today announced that the presentations from May 11 and 12 Depositary Receipts Virtual Investor Conference ("dbVIC") are now available for on-demand viewing. The event featured presentations from international companies with American Depositary Receipt (ADR) programs in the US.
07 May, 2021
Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on Tuesday, May 11 and Wednesday, May 12, featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US.
24 Mar, 2021
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is that...
20 Jan, 2021
The big shareholder groups in Ecofibre Limited ( ASX:EOF ) have power over the company. Generally speaking, as a...
06 Dec, 2020
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
22 Oct, 2020
The latest analyst coverage could presage a bad day for Ecofibre Limited (ASX:EOF), with the covering analyst making...
08 Sep, 2020
When close to half the companies in Australia have price-to-earnings ratios (or "P/E's") below 19x, you may consider...
07 Jul, 2020
Ecofibre Limited (Ecofibre, Company) (ASX:EOF, OTC-NASDAQ Intl Designation: EOFBF) is pleased to announce that the Lankenau Institute for Medical Research1 (LIMR) has begun patient enrollment in a Phase II clinical trial using Ananda Health hemp-derived CBD. The purpose of this study is to assess the efficacy of a hemp-based cannabidiol (CBD) product, Ananda Health Spectrum gelcaps, on the severity and duration of chemotherapy-induced peripheral neuropathy (CIPN) among breast, colon, and ovarian cancer patients who received common types of neurotoxic chemotherapy.